Empowering Leaders at the Global Pharma Executi...

By João L. Carapinha

January 13, 2026

The fourth edition of the Global Pharma Executive Course runs from March to May 2026 at Portugal's Faculdade de Medicina da Universidade Católica Portuguesa and Hospital da Luz Lisboa. The course targets pharma industry leaders, as rapid changes d...
Johnson & Johnson’s Medicine Access Agreement: Paving the Way for ...
NHS Cost-Effectiveness Thresholds Boost Drug Approvals and Innovation
Driving Economic Transformation through Brain Health Investment in Africa
NICE Endorses Natalizumab RRMS Treatment Expansion for Refractory Cases
Childhood Immunization Reforms: Aligning U.S. Schedules with Global Standards
Novartis Drug Pricing Agreement
Africa Medicine Roadmap: Paving the Way for Sustainable Access to Quality Pha...
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
Preparing for the EU Health Technology Assessment: Key Insights from the Upco...
Transforming EU Pharmaceutical Legislation: EMA’s Strategic Priorities ...
Strategic Avalere Health Appointments Enhance Leadership in Navigating US Hea...
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggress...